Scott Sicherer is a Rheumatology/Immunology physician affiliated with Mount Sinai Hospital. OpenAlex indexes 728 publications with 48,212 citations (h-index 107); ClinicalTrials.gov lists 10 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- JAK Inhibition in Food Allergy
Sponsor: Icahn School of Medicine at Mount Sinai
- Systems Biology of Early Atopy
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Overall officialActive, not recruitingNCT04798079 - Immune Basis and Clinical Implications of Threshold-based Phenotypes of Peanut Allergy
Sponsor: Scott Sicherer
Overall officialPhase 2CompletedNCT03907397
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
NIH funding
7 NIH research awards on record, funded 2000–2026 per NIH RePORTER. The latest:
- Immunologic Trajectories of Peanut Desensitization (INROADS)
Icahn School of Medicine at Mount Sinai
FY2026$1,444,950U19AI198423 - Mount Sinai's CoFAR Clinical Research Center
Icahn School of Medicine at Mount Sinai
FY2026$399,999U01AI181883
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”